Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

2021140 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT02718326.

Good health and well-being

Published in: JAMA Ophthalmology

Volume 139, Issue 9, pp. 946-946

Field-Weighted Citation Impact: 19.09